Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists
Authors:
- 5 December 2009
- journal article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 14 (6) , 518-524
Abstract
The aim of this study was to estimate interindividual differences in the antiemetic effects of 5-HT3 receptor antagonists by evaluating the influence of pharmacokinetics on 5-HT3 receptor occupancies, based on receptor occupancy theory. We analyzed interindividual differences of 5-HT3 receptor occupancies and antiemetic effects after the oral and/or intravenous administration of standard doses of the following 5-HT3 receptor antagonists: azasetron, granisetron, indisetron, ondansetron, ramosetron, and tropisetron. The interindividual difference between maximum and minimum 5-HT3 receptor occupancies after oral administration ranged from 0.6% to 64.0%, and that difference after intravenous administration ranged from 0.6% to 29.6%. Following oral administration, the interindividual difference between maximum and minimum complete vomiting inhibition rates ranged from 0.2% to 16.1%. After intravenous administration, that difference ranged from 0.8% to 52.5%. Interindividual differences in the clinical effects of 5-HT3 receptor antagonists could be evaluated based on receptor occupancy theory, and the differences varied among drugs. Drug selection considering these individual variations might be useful for the patients who experienced vomiting associated with chemotherapy.Keywords
This publication has 18 references indexed in Scilit:
- Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patientsCancer Chemotherapy and Pharmacology, 2004
- Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortexNeuropharmacology, 1995
- TropisetronDrugs, 1993
- Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptorsNeurochemistry International, 1993
- Pharmacological Agents Affecting EmesisDrugs, 1992
- High affinity binding of Y-25130 for serotonin 3 receptor.Folia Pharmacologica Japonica, 1992
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Nausea and Vomiting as Major Complications of Cancer ChemotherapyDrugs, 1983